San Jose, California (PRWEB) September 19, 2013
Follow us on LinkedIn – GIA invites senior industry executives, domain experts, technologists and market strategists to participate in a comprehensive global research initiative studying the qPCR and dPCR Instrumentation markets. The study will examine key drivers and trends impacting the market such as increased adoption of advanced gene analysis instrumentation; increased investments in molecular biology research; rise in the number of new uses of qPCR such as in microRNA research, pharmacogenomics, and epigenetics research; intensifying pricing pressures as a result of recently expired and scheduled expiries of patents in the qPCR space; competitive challenges posed by mature market conditions in the qPCR market; growing demand for qPCR reagents as a result of increase in the volume of qPCR procedures; and technology developments and dissolution of barriers to adoption of dPCR.
Touted as important advances over traditional polymerase chain reaction (PCR) method used for quantification and clonal amplification of nucleic acids such as RNS, DNA and cDNA, quantitative real-time PCR (qPCR) and digital PCR (dPCR) instrumentation are witnessing robust growth worldwide. Increased R&D in areas such as, infectious diseases, vaccines, molecular diagnostics, microRNA/ncRNA/siRNA applications, and validation of biomarkers, is expected to benefit growth in the market. qPCR instrumentation market is witnessing the development of affordable solutions targeted at smaller laboratories. In a bid to differentiate product offerings in a relatively mature market, manufacturers are focusing on developing advanced systems with enhanced throughput, improved performance and other value-added features. A positive fallout of patent expiries in qPCR instrumentation is the surge in the commercialization and launch of new qPCR-based diagnostics and research tools.
Digital PCR (dPCR) instrumentation, on the other hand, represents an emerging market. Continuous technology developments are helping lower costs and increase market penetration of dPCR tools. Key benefits of dPCR responsible for driving its adoption in the medical research space include ability to conduct hundreds of PCR amplifications on a single sample; high performance, superior specificity, sensitivity, precision, and robustness; ability to perform absolute quantification at lower costs; and developments in microfluidic tools that help complement the use of dPCR. Clinical laboratories are forecast emerge as a promising end-use market for dPCR platforms in the coming years. dPCR is also expected to find special adoption in the field of cancer research supported by the technology’s unrivalled levels of precision in quantifying cancer-causing genes. Other emerging application areas for dPCR include next-generation sequencing (NGS), identification of rare mutations in genes, gene expression and miRNA analysis, single cell analysis, and pathogen detection.
The study estimates the global qPCR and dPCR Instrumentation market to be a multi-million dollar market, while more precise market-size and growth projections will be made available during the 2nd stage of report preparation, and data analysis.
The research and analyses will be released shortly in the form of a comprehensive research report. The report by design, will attempt to provide exhaustive analysis, data, trends, market share, market size, statistics, forecasts and competitive intelligence. The report is modeled to offer precise and unbiased, actionable market insights including in-depth segmentation of market sub-sectors, demand estimates and projections and analysis of trends in each of the sectors, identification of leading players, and the competitive structure, among others.
Developed for Manufacturers/Vendors, Strategic Planners, Business Development Executives, Management Consultants, Investment Bankers, Consulting Firms, Marketing & Sales Executives, C-Level Decision Makers, Market Strategists and Technology Domain Experts, the report helps identify the biggest opportunities in this space and offers accurate latent demand forecasting that empowers quantitative decision making among existing market players and new entrants.
For more details about how you can participate, please click here.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/
Read the full story at http://www.prweb.com/releases/qPCR_instrumentation/dPCR_instrumentation/prweb11130818.htm.
Copyright©2012 Vocus, Inc.
All rights reserved